Work

Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations. FUNDING: European Commission; European Research Council.
Source: EBioMedicine
Language: English
Open Access status: gold
Estimated APC paid: $5,780
OpenAlex ID: W7226002464
FWCI:
Cites: 73
Cited by:
Related to: 10